Gavin Cooper

Gavin Cooper

Auto-generated profile, based on publicly available information

Gavin Cooper

School of Psychology, University of Newcastle, Callaghan, NSW, Australia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Biological Psychiatry
Verified
Journal Article
Open access
TETheo G.M. van Erp
Theo G.M. van Erp
EWEsther Walton
Esther Walton
DHDerrek P. Hibar
Derrek P. Hibar
LSLianne Schmaal
Lianne Schmaal
WJWenhao Jiang
Wenhao Jiang
FOFunda Orhan
Funda Orhan
The profile of cortical neuroanatomical abnormalities in schizophrenia is not fully understood, despite hundreds of published structural brain imaging studies. This study presents the first meta-analysis of cortical thickness and surface area abnormalities in schizophrenia conducted by the ENIGMA (Enhancing Neuro Imaging Genetics through Meta Analysis) Schizophrenia Working Group. The study included data from 4474 individuals with schizophrenia (mean age, 32.3 years; range, 11-78 years; 66% male) and 5098 healthy volunteers (mean age, 32.8 years; range, 10-87 years; 53% male) assessed with standardized methods at 39 centers worldwide. Compared with healthy volunteers, individuals with schizophrenia have widespread thinner cortex (left/right hemisphere: Cohen's d = -0.530/-0.516) and smaller surface area (left/right hemisphere: Cohen's d = -0.251/-0.254), with the largest effect sizes for both in frontal and temporal lobe regions. Regional group differences in cortical thickness remained significant when statistically controlling for global cortical thickness, suggesting regional specificity. In contrast, effects for cortical surface area appear global. Case-control, negative, cortical thickness effect sizes were two to three times larger in individuals receiving antipsychotic medication relative to unmedicated individuals. Negative correlations between age and bilateral temporal pole thickness were stronger in individuals with schizophrenia than in healthy volunteers. Regional cortical thickness showed significant negative correlations with normalized medication dose, symptom severity, and duration of illness and positive correlations with age at onset. The findings indicate that the ENIGMA meta-analysis approach can achieve robust findings in clinical neuroscience studies; also, medication effects should be taken into account in future genetic association studies of cortical thickness in schizophrenia.

1 September 2020 in NeuroImage
Verified
Journal Article
Open access
Joaquim RaduàJoaquim Raduà
Joaquim Raduà
Eduard VietaEduard Vieta
Eduard Vieta
RSRussell Shinohara
Russell Shinohara
PKPeter Kochunov
Peter Kochunov
YQYann Quide
Yann Quide
JPJulian Pineda-Zapata
Julian Pineda-Zapata
A common limitation of neuroimaging studies is their small sample sizes. To overcome this hurdle, the Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) Consortium combines neuroimaging data from many institutions worldwide. However, this introduces heterogeneity due to different scanning devices and sequences. ENIGMA projects commonly address this heterogeneity with random-effects meta-analysis or mixed-effects mega-analysis. Here we tested whether the batch adjustment method, ComBat, can further reduce site-related heterogeneity and thus increase statistical power. We conducted random-effects meta-analyses, mixed-effects mega-analyses and ComBat mega-analyses to compare cortical thickness, surface area and subcortical volumes between 2897 individuals with a diagnosis of schizophrenia and 3141 healthy controls from 33 sites. Specifically, we compared the imaging data between individuals with schizophrenia and healthy controls, covarying for age and sex. The use of ComBat substantially increased the statistical significance of the findings as compared to random-effects meta-analyses. The findings were more similar when comparing ComBat with mixed-effects mega-analysis, although ComBat still slightly increased the statistical significance. ComBat also showed increased statistical power when we repeated the analyses with fewer sites. Results were nearly identical when we applied the ComBat harmonization separately for cortical thickness, cortical surface area and subcortical volumes. Therefore, we recommend applying the ComBat function to attenuate potential effects of site in ENIGMA projects and other multi-site structural imaging work. We provide easy-to-use functions in R that work even if imaging data are partially missing in some brain regions, and they can be trained with one data set and then applied to another (a requirement for some analyses such as machine learning).

17 October 2007 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
LCLinda E. Campbell
Linda E. Campbell
MHMatthew Hughes
Matthew Hughes
TBTimothy W. Budd
Timothy W. Budd
GCGavin Cooper
Gavin Cooper
WFW. Ross Fulham
W. Ross Fulham
USUlrich Schall
Ulrich Schall

9 December 2013 in Infant Mental Health Journal: Infancy and Early Childhood
Verified
Journal Article
Closed access
PDF file
RERicki-Leigh Elliot
Ricki-Leigh Elliot
LCLinda Campbell
Linda Campbell
MHMick Hunter
Mick Hunter
GCGavin Cooper
Gavin Cooper
JMJessica Melville
Jessica Melville
CLCarmel Loughland
Carmel Loughland

1 October 2011 in Neuropsychologia
Verified
Journal Article
Closed access
JTJuanita Todd
Juanita Todd
APAlexander Provost
Alexander Provost
GCGavin Cooper
Gavin Cooper

10 February 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RARebbekah J. Atkinson
Rebbekah J. Atkinson
WFW. Ross Fulham
W. Ross Fulham
PMPatricia T. Michie
Patricia T. Michie
PWPhilip B. Ward
Philip B. Ward
JTJuanita Todd
Juanita Todd
USUlrich Schall
Ulrich Schall
The onset of schizophrenia is typically preceded by a prodromal period lasting several years during which sub-threshold symptoms may be identified retrospectively. Clinical interviews are currently used to identify individuals who have an ultra-high risk (UHR) of developing a psychotic illness with a view to provision of interventions that prevent, delay or reduce severity of future mental health issues. The utility of bio-markers as an adjunct in the identification of UHR individuals is not yet established. Several event-related potential measures, especially mismatch-negativity (MMN), have been identified as potential biomarkers for schizophrenia. In this 12-month longitudinal study, demographic, clinical and neuropsychological data were acquired from 102 anti-psychotic naive UHR and 61 healthy controls, of whom 80 UHR and 58 controls provided valid EEG data during a passive auditory task at baseline. Despite widespread differences between UHR and controls on demographic, clinical and neuropsychological measures, MMN and P3a did not differ between these groups. Of 67 UHR at the 12-month follow-up, 7 (10%) had transitioned to a psychotic illness. The statistical power to detect differences between those who did or did not transition was limited by the lower than expected transition rate. ERPs did not predict transition, with trends in the opposite direction to that predicted. In exploratory analysis, the strongest predictors of transition were measures of verbal memory and subjective emotional disturbance.